Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells

被引:8
作者
Lamon, Brian D. [1 ]
Summers, Barbara D. [1 ]
Gotto, Antonio M., Jr. [1 ]
Hajjar, David P. [1 ]
机构
[1] Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, Dept Pathol & Lab Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Early growth response (Egr)-1; Statins; Mitogen-activated protein kinase (MAPK); Smooth muscle cells; TISSUE FACTOR EXPRESSION; EARLY GROWTH RESPONSE-1; NF-KAPPA-B; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; EGR-1; EXPRESSION; GENE-EXPRESSION; TARGETING EGR-1; IN-VITRO; INJURY;
D O I
10.1016/j.ejphar.2008.12.047
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Statins have been demonstrated to elicit a broad range of cellular events resulting in an attenuation of the inflammatory response and enhanced protection to the components of the vessel wall. The present study was designed to examine the effect of pitavastatin on pathways associated with the proinflammatory gene, early growth response (Egr)-1 in human vascular smooth muscle cells. Pretreatment with pitavastatin resulted in a dose-dependent reduction in Egr-1 protein and suppressed Egr-1 mRNA expression in response to phorbol 12-myristate 13-acetate (PMA). A reduction in Egr-1 expression reduced the activation of NGFI-A binding protein (NAB)-2, an Egr-1-dependent gene. Furthermore, these events appeared to be dependent on the ability of pitavastatin to attenuate signaling cascades associated with extracellular regulated kinase (ERK) 1/2, but not p38 and c-Jun N-terminal kinase (JNK). (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 33 条
[1]  
Aoki T, 1997, ARZNEIMITTELFORSCH, V47, P904
[2]   Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation [J].
Bea, F ;
Blessing, E ;
Shelley, MI ;
Shultz, JM ;
Rosenfeld, ME .
ATHEROSCLEROSIS, 2003, 167 (02) :187-194
[3]   The pleiotropic effects of statins [J].
Calabrò, P ;
Yeh, ETH .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (06) :541-546
[4]   The cardioprotective effects of statins [J].
Davignon J. .
Current Atherosclerosis Reports, 2004, 6 (1) :27-35
[5]   Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-β type II receptor [J].
Du, BH ;
Fu, CZ ;
Kent, KC ;
Bush, H ;
Schulick, AH ;
Kreiger, K ;
Collins, T ;
McCaffrey, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39039-39047
[6]   Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1 [J].
Fahmy, Roger G. ;
Khachigian, Levon M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) :1526-1535
[7]   Egr-1 target genes in human endothelial cells identified by microarray analysis [J].
Fu, MG ;
Zhu, XJ ;
Zhang, JF ;
Liang, J ;
Lin, YM ;
Zhao, LN ;
Ehrengruber, MU ;
Chen, YQE .
GENE, 2003, 315 :33-41
[8]   Inhibitors of NF-κB signaling:: 785 and counting [J].
Gilmore, T. D. ;
Herscovitch, M. .
ONCOGENE, 2006, 25 (51) :6887-6899
[9]   Involvement of MMPs in the outward remodeling of collateral mesenteric arteries [J].
Haas, Tara L. ;
Doyle, Jennifer L. ;
Distasi, Matthew R. ;
Norton, Laura E. ;
Sheridan, Kevin M. ;
Unthank, Joseph L. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (04) :H2429-H2437
[10]   Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104) [J].
Han, JH ;
Parsons, M ;
Zhou, XY ;
Nicholson, AC ;
Gotto, AM ;
Hajjar, DP .
CIRCULATION, 2004, 110 (22) :3472-3479